Rose John, Cooney Carisa M, Kaufman Christina, Talbot Simon G, Caplan Arthur, Kahn Jeffrey, Sugarman Jeremy, Shores Jaimie T, Levin L Scott, Brandacher Gerald, McDiarmid Sue V, Lee Wp Andrew, Dean Wendy
Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Christine M. Kleinert Institute for Hand and Microsurgery, Louisville, KY, USA.
SAGE Open Med. 2019 Jul 26;7:2050312119866944. doi: 10.1177/2050312119866944. eCollection 2019.
In this article, we present a report from a national meeting titled, "Evolving Issues of Vascularized Composite Allotransplantation-A Symposium on Ethics, Policy, and Reimbursement Issues," which convened in September 2017. We discuss the maturation of vascularized composite allotransplantation from an emerging technology to becoming an extension of clinical practice for select patients with complex reconstructive needs. Viewpoints and action items were presented by and discussed among the 70+ clinicians, researchers, policymakers, ethicists, healthcare administrators, and third-party payers who attended the symposium with the goals of implementing a collaborative roadmap for vascularized composite allotransplantation growth, evaluation, and sustainability by establishing a unified plan to help address concerns of the public, policymakers, and healthcare finance. We review the current status of vascularized composite allotransplantation in clinical practice and summarize symposium discussions regarding ethical considerations, reimbursement, payer strategies, and standardization of data collection.
在本文中，我们呈现了一份来自于2017年9月召开的一场名为“血管化复合组织异体移植的新问题——伦理、政策与报销问题研讨会”的全国性会议的报告。我们探讨了血管化复合组织异体移植从一项新兴技术发展成为针对有复杂重建需求的特定患者的临床实践延伸的过程。70多位临床医生、研究人员、政策制定者、伦理学家、医疗保健管理人员和第三方支付方参加了此次研讨会，他们提出并讨论了各种观点和行动项目，目标是通过制定一项统一计划来实施血管化复合组织异体移植发展、评估和可持续性的协作路线图，以帮助解决公众、政策制定者和医疗保健融资方面的问题。我们回顾了血管化复合组织异体移植在临床实践中的现状，并总结了研讨会关于伦理考量、报销、支付方策略以及数据收集标准化的讨论。
